Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-06

Clinical Trial Update: S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing busulfan to cyclophosphamide as conditioning before total-body irradiation and peripheral stem cell transplantation for advanced myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED